Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Chambers

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Cancer Research|July 1, 1996
Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liverD Hangan, S Uniyal, V L Morris, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)K J Luzzi, H J Varghese, I C MacDonald, et al.
Bone|December 13, 2000
Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesisN L Harris, K R Rattray, C E Tye, et al.
Cancer Research|January 19, 1999
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxisY U Katagiri, J Sleeman, H Fujii, et al.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
Oncogene|September 28, 2005
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinomaC T Miller, L Lin, A M Casper, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Cancer Research|July 1, 1996
Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liverD Hangan, S Uniyal, V L Morris, et al.
Angiogenesis|October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)K J Luzzi, H J Varghese, I C MacDonald, et al.
Bone|December 13, 2000
Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesisN L Harris, K R Rattray, C E Tye, et al.
Cancer Research|January 19, 1999
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxisY U Katagiri, J Sleeman, H Fujii, et al.
British Journal of Cancer|August 9, 2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment responseJ W Thoms, A Dal Pra, P H Anborgh, et al.
Oncogene|September 28, 2005
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinomaC T Miller, L Lin, A M Casper, et al.
Pageof 14